<DOC>
	<DOCNO>NCT01026805</DOCNO>
	<brief_summary>This study assess effectiveness intrauterine fibroid polyp removal use Interlace Medical 1st generation hysteroscopic morcellator device base retrospective review medical record woman treat device .</brief_summary>
	<brief_title>Clinical Evaluation Interlace Medical Hysteroscopic Morcellator</brief_title>
	<detailed_description>A retrospective review medical record eleven ( 11 ) premenopausal woman treat new hysteroscopic morcellator conduct four hospital ambulatory surgical center site . Four physician perform hysteroscopic operative procedure remove intrauterine polyp , type 0 ( completely within uterine cavity ) , type I ( mostly within cavity ) type II ( &lt; 40 % within cavity ) submucous myoma . Percent pathology remove , total morcellation time , total fluid use , fluid deficit treatment-related adverse event assess . Each four treating physician also evaluate device performance use 10 point scale ( 1 = `` poor '' 10 = `` excellent '' ) .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<criteria>female least 18 year old treat intrauterine submucosal fibroid ( Type 0 1 myoma and/or polyp use Interlace 1st generation morcellator device .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>morcellator</keyword>
	<keyword>hysteroscope</keyword>
	<keyword>myomectomy</keyword>
	<keyword>polypectomy</keyword>
	<keyword>uterine fibroid</keyword>
</DOC>